Carisma Therapeutics
Price & Volume
Stats
See more52W Range | $0.38-$2.94 |
Market Cap | $17.4M |
Shares Short | 568,405 |
Financials
See moreRevenue (12 Mos) | $20.2M |
Revenue Growth (YoY) | -11.6% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.52 |
News
See moreYahoo Finance • 8 months ago
Carisma Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
About
CEO | Mr. Steven Kelly |
CFO | Mr. Richard S. Morris CPA |
Address | 3675 Market Street, Philadelphia, PA, United States, 19104 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 107 |
